Mucosal vaccination against diphtheria using starch microparticles as adjuvant for cross-reacting material (CRM197) of diphtheria toxin

Vaccine

Volumn 23, Issue 21, 2005, Pages 2775-2783

  Rydell, Niclas ^a   Sjöholm, Ingvar ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Biodegradable microparticles; CRM197; Diphtheria; Mucosal vaccination

Indexed keywords

ADJUVANT; CROSS REACTING MATERIAL 197; DIPHTHERIA TOXIN; DIPHTHERIA VACCINE; FORMALDEHYDE; STARCH; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIODEGRADATION; CONTROLLED STUDY; CROSS REACTION; DIPHTHERIA; DRUG CONJUGATION; FEMALE; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; VACCINATION;

EID: 15044351347     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.11.049     Document Type: Article

References (31)

1. M.R. Neutra, E. Pringault, and J.P. Kraehenbuhl Antigen sampling across epithelial barriers and induction of mucosal immune responses Annu Rev Immunol 14 1996 275 300
2. C.F. Kuper, P.J. Koornstra, and D.M. Hameleers The role of nasopharyngeal lymphoid tissue Immunol Today 13 1992 219 224
3. M.R. McDermott, and J. Bienenstock Evidence for a common mucosal immunologic system. I. Migration of B immunoblasts into intestinal, respiratory, and genital tissues J Immunol 122 1979 1892 1898
4. C. Czerkinsky, S.J. Prince, and S.M. Michalek IgA antibody-producing cells in peripheral blood after antigen ingestion: evidence for a common mucosal immune system in humans Proc Natl Acad Sci USA 84 1987 2449 2453
5. H.Y. Wu, and M.W. Russell Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system Immunol Res 16 1997 187 201
6. G. Giannini, R. Rappuoli, and G. Ratti The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197 Nucleic Acids Res 12 1984 4063 4069
7. A.M. Pappenheimer Jr., T. Uchida, and A.A. Harper An immunological study of the diphtheria toxin molecule Immunochemistry 9 1972 891 906
8. T.L. Hadfield, P. McEvoy, Y. Polotsky, V.A. Tzinserling, and A.A. Yakovlev The pathology of diphtheria J Infect Dis 181 Suppl. 1 2000 S116 S120
9. R.K. Gupta, R.J. Collier, R. Rappuoli, and G.R. Siber Differences in the immunogenicity of native and formalinized cross reacting material (CRM197) of diphtheria toxin in mice and guinea pigs and their implications on the development and control of diphtheria vaccine based on CRMs Vaccine 15 1997 1341 1343
10. M. Porro, M. Saletti, L. Nencioni, L. Tagliaferri, and I. Marsili Immunogenic correlation between cross-reacting material (CRM197) produced by a mutant of Corynebacterium diphtheriae and diphtheria toxoid J Infect Dis 142 1980 716 724
11. E.A. McNeela, I. Jabbal-Gill, and L. Illum Intranasal immunization with genetically detoxified diphtheria toxin induces T cell responses in humans: enhancement of Th2 responses and toxin-neutralizing antibodies by formulation with chitosan Vaccine 22 2004 909 914
12. E.A. McNeela, D. O'Connor, and I. Jabbal-Gill A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery Vaccine 19 2001 1188 1198
13. E.N. Miyaji, R.P. Mazzantini, and W.O. Dias Induction of neutralizing antibodies against diphtheria toxin by priming with recombinant Mycobacterium bovis BCG expressing CRM(197), a mutant diphtheria toxin Infect Immun 69 2001 869 874
14. N. Rydell, and I. Sjöholm Oral vaccination against diphtheria using polyacryl starch microparticles as adjuvant Vaccine 22 2004 1265 1274
15. K.H. Mills, C. Cosgrove, and E.A. McNeela Protective levels of diphtheria-neutralizing antibody induced in healthy volunteers by unilateral priming-boosting intranasal immunization associated with restricted ipsilateral mucosal secretory immunoglobulin a Infect Immun 71 2003 726 732
16. P. Artursson, P. Edman, T. Laakso, and I. Sjoholm Characterization of polyacryl starch microparticles as carriers for proteins and drugs J Pharm Sci 73 1984 1507 1513
17. T. Laakso, P. Artursson, and I. Sjöholm Biodegradable microspheres. IV. Factors affecting the distribution and degradation of polyacryl starch microparticles J Pharm Sci 75 1986 962 967
18. G.S. Bethell, J.S. Ayers, W.S. Hancock, and M.T. Hearn A novel method of activation of cross-linked agaroses with 1,1′-carbonyldiimidazole which gives a matrix for affinity chromatography devoid of additional charged groups J Biol Chem 254 1979 2572 2574
19. K. Miyamura, N. Shigeko, A. Ito, R. Murata, and R. Kono Micro cell culture method for determination of diphtheria toxin and antitoxin titers using VERO cells J Biol Stand 2 1974 189 201
20. J. Petre, M. Pizza, L. Nencioni, A. Podda, M.T. De Magistris, and R. Rappuoli The reaction of bacterial toxins with formaldehyde and its use for antigen stabilization Dev Biol Stand 87 1996 125 134
21. K. Östh, L. Strindelius, and A. Larhed Uptake of ovalbumin-conjugated starch microparticles by pig respiratory nasal mucosa in vitro J Drug Target 11 2003 75 82
22. B. Metz, W. Jiskoot, W.E. Hennink, D.J. Crommelin, and G.F. Kersten Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines Vaccine 22 2003 156 167
23. A. Larhed, L. Stertman, E. Edvardsson, and I. Sjöholm Starch microparticles as oral vaccine adjuvant: antigen-dependent uptake in mouse intestinal mucosa J Drug Target 12 2004 289 296
24. L. Wikingsson, and I. Sjöholm Polyacryl starch microparticles as adjuvant in oral immunisation, inducing mucosal and systemic immune responses in mice Vaccine 20 2002 3355 3363
25. D.D. Ourth Neutralization of diphtheria toxin by human immunoglobulin classes and subunits Immunochemistry 11 1974 223 225
26. R. Rappuoli New and improved vaccines against diphtheria and tetanus M.M. Levine G.C. Woodrow J.B. Kapler G.S. Cobon New generation vaccines 1997 Marcel Dekker New York 417 436
27. O. Simonsen, K. Kjeldsen, H.A. Vendborg, and I. Heron Revaccination of adults against diphtheria. I. Responses and reactions to different doses of diphtheria toxoid in 30-70-year-old persons with low serum antitoxin levels Acta Pathol Microbiol Immunol Scand 94 1986 213 218
28. C. von Hunolstein, H. Aggerbeck, and N. Andrews European sero-epidemiology network: standardisation of the results of diphtheria antitoxin assays Vaccine 18 2000 3287 3296
29. H. HogenEsch Mechanisms of stimulation of the immune response by aluminum adjuvants Vaccine 20 Suppl. 3 2002 S34 S39
30. H. Aggerbeck, S. Gizurarson, J. Wantzin, and I. Heron Intranasal booster vaccination against diphtheria and tetanus in man Vaccine 15 1997 307 316
31. L. Illum, A.N. Fisher, I. Jabbal-Gill, and S.S. Davis Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides Int J Pharm 222 2001 109 119